Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676104 · ClinicalTrials.gov registry record · Phase 3
Discrete Hypothermia in the Management of Traumatic Brain Injury
A Phase 3 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 3
- Development phase
- 25
- Enrollment target
NCT00676104 is a Phase 3 study that has completed, run by Emory University. The registered enrollment target is 25 participants.
The verdict
NCT00676104, a Phase 3 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 25 participants
- Enrollment target
Study Summary
The primary goal of this project is to demonstrate the feasibility and clinical benefits of a new rapid treatment for secondary treatment for secondary brain injury called Discrete Cerebral Hypothermia System by CoolSystems, Inc., Berkley, CA. This device induced hypothermia in the adult brain without significant whole body hypothermia. Discrete Cerebral Hypothermia System holds a great potential for protecting the brain from the devastating secondary complications of trauma without the associated deleterious system effects.
Interventions
- DEVICE CoolSystems Discrete Cerebral Hypothermia System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00676104
The ClinicalTrials.gov registry entry for NCT00676104 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CoolSystems Discrete Cerebral Hypothermia System is the first listed.
NCT00676104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00676104 about?
NCT00676104 is a clinical study titled "Discrete Hypothermia in the Management of Traumatic Brain Injury". The primary goal of this project is to demonstrate the feasibility and clinical benefits of a new rapid treatment for secondary treatment for secondary brain injury called Discrete Cerebral Hypothermia System by CoolSystems, Inc., Berkley, CA. This device induced hypothermia in the adult brain witho...
What is the current status of trial NCT00676104?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 25 participants. The study started on 2006-07. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00676104?
The interventions under investigation include: CoolSystems Discrete Cerebral Hypothermia System (DEVICE).
Who is sponsoring clinical trial NCT00676104?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.